A5059603961- Pharmaceutical studies and practices
- Antibiotics Pharmacokinetics and Efficacy
- Pharmaceutical Practices and Patient Outcomes
- Pneumonia and Respiratory Infections
- Anesthesia and Sedative Agents
- Antibiotic Resistance in Bacteria
- Medication Adherence and Compliance
- Pharmacological Effects and Toxicity Studies
- Neonatal Respiratory Health Research
- Antimicrobial Resistance in Staphylococcus
- Epilepsy research and treatment
- Innovations in Medical Education
- Pediatric Pain Management Techniques
- Analytical Methods in Pharmaceuticals
- Patient Safety and Medication Errors
- Health Sciences Research and Education
- Bacterial Infections and Vaccines
- Metabolism and Genetic Disorders
- Pharmaceutical Economics and Policy
- Health Systems, Economic Evaluations, Quality of Life
- Respiratory viral infections research
- HIV/AIDS drug development and treatment
- Cystic Fibrosis Research Advances
- Poisoning and overdose treatments
- Complementary and Alternative Medicine Studies
The Ohio State University
2016-2025
American Association of Colleges of Pharmacy
2008-2024
Medication Management (United States)
2020
National Park Service
2020
Nationwide Children's Hospital
2004-2019
American Pharmacists Association
2003-2019
Ohio Supercomputer Center
2017
The Ohio State University Wexner Medical Center
1997-2012
Charleston Area Medical Center
2011
American College of Clinical Pharmacy
2010
While laboratory and clinical benefits of hydroxyurea for patients with sickle cell disease (SCD) are well-established, few data describe the extent implications non-adherence. We sought to assess adherence among SCD investigate associations between economic outcomes. Insurance claims North Carolina Medicaid enrollees (6/2000-8/2008) were analyzed. Inclusion criteria included age < 65 years, continuous enrollment ≥ 12 months before following initiation, 2 prescriptions. Three hundred twelve...
Abstract Background This study aims to evaluate the efficacy and safety of vonoprazan‐amoxicillin (VA), vonoprazan‐amoxicillin‐clarithromycin (VAC), vonoprazan‐based bismuth‐containing quadruple therapy (VBQT), PPI‐based triple (PAC) or (PBQT) for H. pylori infection with consideration duration amoxicillin dose (H: high; L: low). Materials Methods PubMed, Embase, Cochrane Central Register Controlled Trials were searched eligible randomized controlled trials (RCTs) up December 15, 2023. The...
A combination of meperidine (M) 25 mg/ml, promethazine (P) 6.5 and chlorpromazine (C) mg/ml is widely used to produce sedation in pediatric patients. dose MPC 0.1 ml/kg recommended for cardiac catheterization, but no specific guidelines dosing or frequency monitoring have been established patients undergoing other types procedures. The adverse effects were studied prospectively 95 various was given parenterally at a 0.07-0.11 ml/kg. Four developed respiratory depression. In these patients,...
Many drugs frequently used in infants and young children are not available suitable dosage forms. Liquid forms must be prepared extemporaneously, while using appropriate excipients. However, it is critical to determine the stability of various at clinically important concentrations practical storage conditions. It concern that few funding agencies willing support research on development stable liquid for pediatric patients. The need such data will continue, because unlikely all approved...
Amphotericin B is the most effective agent for majority of systemic fungal infections but often causes toxicity, and specific dosage guidelines amphotericin in pediatric patients are lacking. The purpose this study was to characterize pharmacokinetics children. Twelve (mean age, 6.6 years; range, 4 months 14 years) receiving B, 0.68 +/- 0.34 mg/kg per day plus or minus standard deviation), were studied. Four eight blood samples collected during a 24-h period analyzed by high-pressure liquid...
This cross-sectional study uses data from the National Survey on Drug Use and Health (NSDUH) to investigate trends in substance use disorder treatment need receipt 2013 2023 among US population.
Abstract Introduction The prevalence of exposure to supratherapeutic doses or contraindicated medications based on renal dosing criteria, also known as potentially inappropriately prescribed (PIPM), is currently unknown among patients peritoneal dialysis (PD). primary objective this study was evaluate the PIPM in first year PD Medicare United States. Methods This a retrospective longitudinal cohort analysis starting 2018 States Renal Data System database. Inclusion criteria were >65 years...